— Know what they know.
Not Investment Advice

GENPF OTC

Genix Pharmaceuticals Corporation
1W: +0.0% 1M: +0.0% 3M: -8.6% YTD: -54.0% 1Y: +0.0% 3Y: -90.6%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 44 · $844893 mcap · 52M float · 0.0004% daily turnover · Short 88% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.8M
52W Range0.0138-0.03573
Volume2,000
Avg Volume200
Beta0.40
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSina Salehi Pirooz
Employees4,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-02-18
1055 West Hastings Street
Vancouver, BC V6E 2E9
CA
+1 604 609 6198
About Genix Pharmaceuticals Corporation

Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms